Aviva PLC Has $202 Million Stake in UnitedHealth Group Inc (UNH)

Aviva PLC decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 6.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The fund owned 759,290 shares of the healthcare conglomerate’s stock after selling 48,835 shares during the quarter. UnitedHealth Group accounts for about 1.1% of Aviva PLC’s investment portfolio, making the stock its 14th biggest position. Aviva PLC owned 0.08% of UnitedHealth Group worth $202,002,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in UNH. FMR LLC grew its stake in shares of UnitedHealth Group by 5.1% during the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock valued at $15,118,428,000 after buying an additional 2,981,233 shares during the last quarter. Vontobel Asset Management Inc. bought a new position in UnitedHealth Group in the second quarter worth approximately $404,980,000. Janus Henderson Group PLC grew its stake in UnitedHealth Group by 61.7% in the second quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock worth $864,869,000 after purchasing an additional 1,345,083 shares in the last quarter. Chevy Chase Trust Holdings Inc. bought a new position in UnitedHealth Group in the second quarter worth approximately $248,898,000. Finally, Jennison Associates LLC grew its stake in UnitedHealth Group by 12.0% in the second quarter. Jennison Associates LLC now owns 6,616,652 shares of the healthcare conglomerate’s stock worth $1,623,329,000 after purchasing an additional 710,745 shares in the last quarter. 85.57% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group stock opened at $269.18 on Friday. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. The firm has a market cap of $267.97 billion, a price-to-earnings ratio of 26.73, a P/E/G ratio of 1.60 and a beta of 0.76. UnitedHealth Group Inc has a twelve month low of $208.48 and a twelve month high of $287.94.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, topping analysts’ consensus estimates of $3.30 by $0.11. The company had revenue of $56.56 billion during the quarter, compared to analyst estimates of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. UnitedHealth Group’s revenue was up 12.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $2.66 earnings per share. Analysts anticipate that UnitedHealth Group Inc will post 12.82 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Friday, November 30th. This represents a $3.60 dividend on an annualized basis and a yield of 1.34%. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

Several brokerages recently issued reports on UNH. BMO Capital Markets increased their price objective on UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a research note on Thursday, October 18th. Cantor Fitzgerald reissued a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research note on Wednesday, November 21st. Piper Jaffray Companies increased their price objective on UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 17th. Raymond James increased their price objective on UnitedHealth Group from $304.00 to $310.00 and gave the stock a “strong-buy” rating in a research note on Wednesday, October 17th. Finally, Royal Bank of Canada increased their price objective on UnitedHealth Group to $308.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 17th. Two analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $292.48.

In other UnitedHealth Group news, Director Richard T. Burke sold 20,000 shares of the company’s stock in a transaction on Wednesday, September 12th. The stock was sold at an average price of $263.41, for a total transaction of $5,268,200.00. Following the completion of the sale, the director now owns 1,720,112 shares in the company, valued at $453,094,701.92. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Richard T. Burke sold 6,090 shares of the company’s stock in a transaction on Wednesday, November 28th. The stock was sold at an average price of $281.72, for a total value of $1,715,674.80. Following the sale, the director now owns 1,711,584 shares of the company’s stock, valued at approximately $482,187,444.48. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 34,395 shares of company stock valued at $9,186,302. 0.87% of the stock is owned by company insiders.

COPYRIGHT VIOLATION NOTICE: This piece was published by American Banking News and is the sole property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and reposted in violation of United States & international copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/12/08/aviva-plc-has-202-million-stake-in-unitedhealth-group-inc-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Recommended Story: Day Trading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply